Cargando…
Relation of Serum Copper Status to Survival in COVID-19
The trace element copper (Cu) is part of our nutrition and essentially needed for several cuproenzymes that control redox status and support the immune system. In blood, the ferroxidase ceruloplasmin (CP) accounts for the majority of circulating Cu and serves as transport protein. Both Cu and CP beh...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229409/ https://www.ncbi.nlm.nih.gov/pubmed/34072977 http://dx.doi.org/10.3390/nu13061898 |
_version_ | 1783712970296000512 |
---|---|
author | Hackler, Julian Heller, Raban Arved Sun, Qian Schwarzer, Marco Diegmann, Joachim Bachmann, Manuel Moghaddam, Arash Schomburg, Lutz |
author_facet | Hackler, Julian Heller, Raban Arved Sun, Qian Schwarzer, Marco Diegmann, Joachim Bachmann, Manuel Moghaddam, Arash Schomburg, Lutz |
author_sort | Hackler, Julian |
collection | PubMed |
description | The trace element copper (Cu) is part of our nutrition and essentially needed for several cuproenzymes that control redox status and support the immune system. In blood, the ferroxidase ceruloplasmin (CP) accounts for the majority of circulating Cu and serves as transport protein. Both Cu and CP behave as positive, whereas serum selenium (Se) and its transporter selenoprotein P (SELENOP) behave as negative acute phase reactants. In view that coronavirus disease (COVID-19) causes systemic inflammation, we hypothesized that biomarkers of Cu and Se status are regulated inversely, in relation to disease severity and mortality risk. Serum samples from COVID-19 patients were analysed for Cu by total reflection X-ray fluorescence and CP was quantified by a validated sandwich ELISA. The two Cu biomarkers correlated positively in serum from patients with COVID-19 (R = 0.42, p < 0.001). Surviving patients showed higher mean serum Cu and CP concentrations in comparison to non-survivors ([mean+/−SEM], Cu; 1475.9+/−22.7 vs. 1317.9+/−43.9 µg/L; p < 0.001, CP; 547.2.5+/−19.5 vs. 438.8+/−32.9 mg/L, p = 0.086). In contrast to expectations, total serum Cu and Se concentrations displayed a positive linear correlation in the patient samples analysed (R = 0.23, p = 0.003). Serum CP and SELENOP levels were not interrelated. Applying receiver operating characteristics (ROC) curve analysis, the combination of Cu and SELENOP with age outperformed other combinations of parameters for predicting risk of death, yielding an AUC of 95.0%. We conclude that the alterations in serum biomarkers of Cu and Se status in COVID-19 are not compatible with a simple acute phase response, and that serum Cu and SELENOP levels contribute to a good prediction of survival. Adjuvant supplementation in patients with diagnostically proven deficits in Cu or Se may positively influence disease course, as both increase in survivors and are of crucial importance for the immune response and antioxidative defence systems. |
format | Online Article Text |
id | pubmed-8229409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82294092021-06-26 Relation of Serum Copper Status to Survival in COVID-19 Hackler, Julian Heller, Raban Arved Sun, Qian Schwarzer, Marco Diegmann, Joachim Bachmann, Manuel Moghaddam, Arash Schomburg, Lutz Nutrients Article The trace element copper (Cu) is part of our nutrition and essentially needed for several cuproenzymes that control redox status and support the immune system. In blood, the ferroxidase ceruloplasmin (CP) accounts for the majority of circulating Cu and serves as transport protein. Both Cu and CP behave as positive, whereas serum selenium (Se) and its transporter selenoprotein P (SELENOP) behave as negative acute phase reactants. In view that coronavirus disease (COVID-19) causes systemic inflammation, we hypothesized that biomarkers of Cu and Se status are regulated inversely, in relation to disease severity and mortality risk. Serum samples from COVID-19 patients were analysed for Cu by total reflection X-ray fluorescence and CP was quantified by a validated sandwich ELISA. The two Cu biomarkers correlated positively in serum from patients with COVID-19 (R = 0.42, p < 0.001). Surviving patients showed higher mean serum Cu and CP concentrations in comparison to non-survivors ([mean+/−SEM], Cu; 1475.9+/−22.7 vs. 1317.9+/−43.9 µg/L; p < 0.001, CP; 547.2.5+/−19.5 vs. 438.8+/−32.9 mg/L, p = 0.086). In contrast to expectations, total serum Cu and Se concentrations displayed a positive linear correlation in the patient samples analysed (R = 0.23, p = 0.003). Serum CP and SELENOP levels were not interrelated. Applying receiver operating characteristics (ROC) curve analysis, the combination of Cu and SELENOP with age outperformed other combinations of parameters for predicting risk of death, yielding an AUC of 95.0%. We conclude that the alterations in serum biomarkers of Cu and Se status in COVID-19 are not compatible with a simple acute phase response, and that serum Cu and SELENOP levels contribute to a good prediction of survival. Adjuvant supplementation in patients with diagnostically proven deficits in Cu or Se may positively influence disease course, as both increase in survivors and are of crucial importance for the immune response and antioxidative defence systems. MDPI 2021-05-31 /pmc/articles/PMC8229409/ /pubmed/34072977 http://dx.doi.org/10.3390/nu13061898 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hackler, Julian Heller, Raban Arved Sun, Qian Schwarzer, Marco Diegmann, Joachim Bachmann, Manuel Moghaddam, Arash Schomburg, Lutz Relation of Serum Copper Status to Survival in COVID-19 |
title | Relation of Serum Copper Status to Survival in COVID-19 |
title_full | Relation of Serum Copper Status to Survival in COVID-19 |
title_fullStr | Relation of Serum Copper Status to Survival in COVID-19 |
title_full_unstemmed | Relation of Serum Copper Status to Survival in COVID-19 |
title_short | Relation of Serum Copper Status to Survival in COVID-19 |
title_sort | relation of serum copper status to survival in covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229409/ https://www.ncbi.nlm.nih.gov/pubmed/34072977 http://dx.doi.org/10.3390/nu13061898 |
work_keys_str_mv | AT hacklerjulian relationofserumcopperstatustosurvivalincovid19 AT hellerrabanarved relationofserumcopperstatustosurvivalincovid19 AT sunqian relationofserumcopperstatustosurvivalincovid19 AT schwarzermarco relationofserumcopperstatustosurvivalincovid19 AT diegmannjoachim relationofserumcopperstatustosurvivalincovid19 AT bachmannmanuel relationofserumcopperstatustosurvivalincovid19 AT moghaddamarash relationofserumcopperstatustosurvivalincovid19 AT schomburglutz relationofserumcopperstatustosurvivalincovid19 |